Related Experiment Video
Updated: Sep 23, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
How abnormal calcium, phosphate, and parathyroid hormone relate to cardiovascular disease
1Righospitalet, University of Copenhagen, Copenhagen, Denmark.
Insights
Patients with chronic kidney disease (CKD) face premature cardiovascular disease. Managing imbalances in calcium, phosphate, and parathyroid hormone (PTH) may improve survival in these patients.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality in patients with chronic kidney disease (CKD).
- Physiological changes in CKD contribute to premature CVD development and increased cardiovascular mortality.
- Emerging evidence links mineral and bone disorders, specifically abnormal calcium, phosphate, and parathyroid hormone (PTH) levels, to CVD in CKD.
Purpose of the Study:
- To investigate the association between mineral and bone disorders and cardiovascular disease in chronic kidney disease patients.
- To highlight the potential impact of managing calcium, phosphate, and PTH imbalances on cardiovascular outcomes in CKD.
Main Methods:
- Review of recent studies and clinical evidence.
- Analysis of the relationship between specific biomarkers (calcium, phosphate, PTH) and cardiovascular events in CKD populations.
Main Results:
- Abnormal levels of calcium, phosphate, and PTH are significantly associated with cardiovascular disease in patients with CKD.
- These mineral and bone derangements are implicated in the pathophysiology of premature CVD in this cohort.
Conclusions:
- Intensive management and prevention of calcium, phosphate, and PTH imbalances are crucial in CKD care.
- Targeting these metabolic derangements may offer a therapeutic strategy to improve survival and reduce cardiovascular mortality in patients with chronic kidney disease.
Abstract:
Cardiovascular disease tends to develop prematurely in patients who have chronic kidney disease (CKD). The physiological changes that specifically arise from this disease likely account for the resulting high incidence of cardiovascular mortality. Recent studies indicate that abnormal calcium, phosphate, and parathyroid hormone (PTH) levels are associated with cardiovascular disease in CKD. This new evidence suggests that an intensive approach to the prevention and treatment of these imbalances may contribute to improved survival of patients with CKD.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Bone Remodeling

